{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:28:17Z","timestamp":1794472097121,"version":"4.9.1"},"reference-count":43,"publisher":"Korean Stroke Society","issue":"2","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Ministry of Science and Technology"},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Stroke Association"},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"crossref","award":["2017ZX09304018"],"award-info":[{"award-number":["2017ZX09304018"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["2022YFC3600600"],"award-info":[{"award-number":["2022YFC3600600"]}]},{"name":"Training Fund for Open Projects at Clinical Institutes and Departments of Capital Medical University","award":["CCMU2022ZKYXZ009"],"award-info":[{"award-number":["CCMU2022ZKYXZ009"]}]},{"name":"Beijing Natural Science Foundation Haidian original innovation joint fund","award":["L222123"],"award-info":[{"award-number":["L222123"]}]},{"name":"Fund for Young Talents of Beijing Medical Management Center","award":["QML20230505"],"award-info":[{"award-number":["QML20230505"]}]}],"content-domain":{"domain":["j-stroke.org"],"crossmark-restriction":true},"short-container-title":["J Stroke"],"published-print":{"date-parts":[[2024,5,31]]},"abstract":"<jats:p>Background and Purpose Non-high-density lipoprotein cholesterol (non-HDL-C), which represents the total cholesterol content of all pro-atherogenic lipoproteins, has recently been included as a new target for lipid-lowering therapy in high-risk atherosclerotic patients in multiple guidelines. Herein, we aimed to explore the relationship between non-HDL-C level and the efficacy and safety of ticagrelor-aspirin versus clopidogrel-aspirin in preventing stroke recurrence.Methods This study comprised a post hoc analysis of the CHANCE-2 (Ticagrelor or Clopidogrel in High-Risk Patients with Acute Nondisabling Cerebrovascular Events II) trial, from which 5,901 patients with complete data on non-HDL-C were included and categorized by median non-HDL-C levels, using a cutoff of 3.5 mmol\/L. The primary efficacy and safety outcomes were recurrent stroke and severe or moderate bleeding within 90 days.Results Ticagrelor-aspirin significantly reduced the risk of recurrent stroke in patients with low non-HDL-C (71 [4.8%] vs. 119 [7.7%]; adjusted hazard ratio [HR] 0.54; 95% confidence interval [CI], 0.40\u20130.74), but not in those with high non-HDL-C (107 [7.3%] vs. 108 [7.6%]; adjusted HR, 0.88; 95% CI, 0.67\u20131.16), compared with clopidogrel-aspirin (P for interaction=0.010). When analyzed as a continuous variable, the benefit of ticagrelor-aspirin for recurrent stroke decreased as non-HDL-C levels increased. No significant differences in the treatment assignments across the non-HDL-C groups were observed in terms of the rate of severe or moderate bleeding (5 [0.3%] vs. 8 [0.5%] in the low non-HDL-C group; 4 [0.3%] vs. 2 [0.1%] in the high non-HDL-C group; P for interaction=0.425).Conclusion CHANCE-2 participants with low non-HDL-C levels received more clinical benefit from ticagrelor-aspirin versus clopidogrel-aspirin compared to those with high non-HDL-C, following minor ischemic stroke or transient ischemic attack.<\/jats:p>","DOI":"10.5853\/jos.2024.00367","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T01:40:46Z","timestamp":1717119646000},"page":"231-241","update-policy":"https:\/\/doi.org\/10.5853\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Influence of Non-High-Density Lipoprotein Cholesterol on the Efficacy of Genotype-Guided Dual Antiplatelet Therapy in Preventing Stroke Recurrence"],"prefix":"10.5853","volume":"26","author":[{"given":"Qin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4351-2877","authenticated-orcid":true,"given":"Anxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-2341","authenticated-orcid":true,"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3882","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04169-8"},{"key":"ref2","first-page":"1330","volume-title":"Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke","author":"Li","year":"2015"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.116.014761"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.12551"},{"key":"ref5","first-page":"e023223","volume-title":"Hyperglycemia, risk of subsequent stroke, and efficacy of dual antiplatelet therapy: a post hoc analysis of the point trial","author":"Mac Grory","year":"2022"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.122.038662"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/m22-1667"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwac219"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.3.326"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.104.532499"},{"key":"ref11","first-page":"2173","volume-title":"Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium","author":"Brunner","year":"2019"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.01.027"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.107.713438"},{"key":"ref14","first-page":"e1082","volume-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","author":"Grundy","year":"2019"},{"key":"ref15","first-page":"111","volume-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","author":"Mach","year":"2020"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2021.03.016"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063180"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061995"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm.2021.01.256"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.01.015"},{"key":"ref21","first-page":"2520","volume-title":"Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA","author":"Wang","year":"2021"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2020-000791"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199309023291001"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.04.027"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/mjt.0000000000001099"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.25.2.275"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2018.81035"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/nejm197402212900805"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v68.2.498.bloodjournal682498"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-631259"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.p037614"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.5551\/jat.6288"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1758654"},{"key":"ref34","first-page":"e364","volume-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","author":"Kleindorfer","year":"2021"},{"key":"ref35","first-page":"1960","volume-title":"Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: the VLDL-2 study (very large database of lipids)","author":"Elshazly","year":"2013"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13973"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-06472-3"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.2658"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.113.003657"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.120.030783"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-154-10-201105170-00008"},{"key":"ref43","first-page":"70","volume-title":"Trajectories of non-HDL cholesterol across midlife: implications for cardiovascular prevention","author":"Pencina","year":"2019"}],"container-title":["Journal of Stroke"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/j-stroke.org\/upload\/pdf\/jos-2024-00367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/j-stroke.org\/journal\/view.php?doi=10.5853\/jos.2024.00367","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/j-stroke.org\/upload\/pdf\/jos-2024-00367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T06:41:46Z","timestamp":1717569706000},"score":1,"resource":{"primary":{"URL":"http:\/\/j-stroke.org\/journal\/view.php?doi=10.5853\/jos.2024.00367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"URL":"https:\/\/doi.org\/10.5853\/jos.2024.00367","relation":{},"ISSN":["2287-6391","2287-6405"],"issn-type":[{"value":"2287-6391","type":"print"},{"value":"2287-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]},"assertion":[{"value":"2024-01-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-30","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-31","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}